MRS differentiates MCI patients who progress to dementia with Lewy bodies and Alzheimer's disease

bing zhang,tanis j ferman,bradley f boeve,glenn e smith,mandie maroneysmith,david s knopman,clifford r jack,ronald c petersen,kejal kantarci

DOI: https://doi.org/10.1016/j.jalz.2013.05.056

2013-01-01

Abstract:Although Alzheimer's disease (AD) accounts for the majority of patients with mild cognitive impairment (MCI), other dementia etiologies such as dementia with Lewy bodies (DLB) may also be important. Our objective was to investigate the regional proton magnetic resonance spectroscopy (MRS) characteristics of patients with MCI who progressed to DLB compared to patients with MCI who progressed to AD dementia or who remained stable during a median follow-up period of 18 months. Consecutive patients with MCI who underwent MRS studies at baseline and progressed to the diagnosis of DLB after a median follow-up period of 18 months (n=10) were identified from the Mayo Clinic AD Research Center and Mayo Clinic Study of Aging. From the same cohort, we identified age- and sex-matched MCI patients who progressed to AD (n=27) or remained stable (n=20) during a similar time interval. Single voxel MRS studies were performed from the posterior cingulate gyri, medial frontal and occipital lobe voxels. Differences in MRS metabolite ratios to creatine (Cr) among MCI patients who progressed to DLB, AD or remained stable were tested with Wilcoxon rank sum tests. Amnestic (single and multi-domain) MCI accounted for 81% of the 27 patients who progressed AD, while only half (50%) of the 10 patients with MCI who progressed to DLB were diagnosed with amnestic MCI. At baseline, patients with MCI who progressed to AD were characterized by lower N-acetylaspartate to Cr (NAA/Cr) ratio in the posterior cingulate voxel compared to MCI patients who progressed to DLB (p= 0.001) and the stable MCI patients (p=0.07) (Figure). Decreased NAA/Cr levels in the posterior cingulate voxel differentiated MCI patients who progressed to DLB from those who progressed to AD with an accuracy of 85%, specificity of 89% and sensitivity of 80%. Figure. Posterior cingulate voxel (2×2×2cm) (A) placed on a mid-sagittal MPRAGE image. Spectra from the posterior cingulate voxel demonstrate decreased NAA in a patient with MCI progressed to AD (B) compared with a patient with MCI who progressed to DLB (C). All spectra are scaled to the height of the reference peak Cr, shown with a dotted line (B and C). Box plots show the differences in NAA/Cr among MCI patients who progressed to AD (MCI/AD) (n=23), DLB (MCI/DLB) (n=10), * p value =0.001 (D).